Navana Pharmaceuticals PLC Stock

Navana Pharmaceuticals PLC., formerly Navana Pharmaceuticals Limited, is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing, marketing, and distribution of pharmaceutical products for human and animal health products and sales of the produced items in the domestic and foreign market. It operates in two segments: Human Health and Veterinary. The Human Health segment is engaged in manufacturing marketing and selling of pharmaceutical products. It produces tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams, ointments, and others. The Veterinary segment is engaged in manufacturing marketing distributing and selling of veterinary, poultry and fisheries products. The Company's products include Pmec, Stenide Cream, Agonil Cream, Vontac Tablet, Floxacin, Inpen, Osmina, Methebac, Kcit, Ezitor, Droniva, Ospemifene, Ferri Maltol, Lvofloxacin, Nafgal, Esona, Clonipres, Meltix, Diplin, and Arokast, among others.